UNC93B1

Protein unc-93 homolog B1 · Q9H1C4 · UNC93B1 on Sugi Atlas →

0 patent compounds predicted against UNC93B1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UNC93B1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Understanding the Immune Response to Two Different Meningitis Vaccines PHASE4COMPLETED
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation PHASE2/PHASE3UNKNOWN
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders nanCOMPLETED
Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in MYO7A nanRECRUITING
Inherited Reproductive Disorders nanRECRUITING
Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC) nanRECRUITING
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity nanUNKNOWN
Genome-Wide Assocation Study in Patients With Brain Injury Associated Fatigue and Altered Cognition (BIAFAC) nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis) nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
Chordoma Family Study nanCOMPLETED
Natural History and Genetic Studies of Usher Syndrome nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Study of Constitutional Platelet Disease nanUNKNOWN
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles nanACTIVE_NOT_RECRUITING
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Autophagy Bladder Cancer nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a UNC93B1 binder may also engage these)

ProteinNameSimilarity
Q8VCW4 0.991 Q8VCW4 →
Q7RTT9 0.955 Q7RTT9 →
Q9BSA9 0.947 Q9BSA9 →
Q8N9F0 0.943 Q8N9F0 →
Q8NBT3 0.942 Q8NBT3 →
D3ZXD8 0.941 D3ZXD8 →
A6NDV4 0.941 A6NDV4 →
Q8R139 0.940 Q8R139 →
B1AWJ5 0.938 B1AWJ5 →
D3ZVU9 0.938 D3ZVU9 →
Q9UPR3 0.938 Q9UPR3 →
Q9H330 0.938 Q9H330 →
Q2YDG0 0.937 Q2YDG0 →
E1BD52 0.937 E1BD52 →
B1AZA5 0.937 B1AZA5 →
F1NJ67 0.936 F1NJ67 →
Q5R5F8 0.936 Q5R5F8 →
O42224 0.936 O42224 →
Q8CIF6 0.936 Q8CIF6 →
Q9NVE7 0.936 Q9NVE7 →
Q3UGX3 0.935 Q3UGX3 →
Q6AY05 0.935 Q6AY05 →
Q0GA42 0.935 Q0GA42 →
Q04671 0.935 Q04671 →
D3ZEH5 0.934 D3ZEH5 →
Q6ZN54 0.934 Q6ZN54 →
Q5U239 0.933 Q5U239 →
SMO Protein smoothened 0.933 landscape →
A5PJM7 0.933 A5PJM7 →
Q6GQT6 0.933 Q6GQT6 →